Right Colectomy for Colon Cancer Database (RCC). Surgical Technique, Route of Access and Quality of the Specimen
RCC
1 other identifier
observational
1,000
1 country
1
Brief Summary
Aim of the project is to surveil results after extended lymphadenectomy for right sided colon resection for cancer with different operative techniques. Patients operated for right sided colon cancer will be involved. There are different operative methods used in terms of extend of lymphadenectomy and access (open, laparoscopic and robotic assisted) that are already implemented. The Norwegian standard operation contains less extended lymph node dissection. Patients operated by the standard method will serve as control group. Choice of access and extend of lymph node dissection in Norway is dependant on the surgeon and hospital. At Haukeland University Hospital extend and access of surgery are determined by a multidisciplinary team meeting. More radical surgery might result in more complications and the benefit for the patients in terms of oncological result and survival is uncertain. At Haukeland University Hospital, extended lymphadenectomy has been mostly performed by open surgery. During the study phase we will introduce extended lymphadenectomy by laparoscopy and robotassisted surgery. Hypothesis is that more radical surgery performed by minimal invasive surgery will result in equal or better oncological results, and less complications, shorter hospital stay and better quality of life. As method we choose a prospective observational study. All eligible patients with adenocarcinoma of the right colon without another ongoing oncological treatment for other cancers will be included. Patientdata will be prospectively registered in a web-based database. Aim of the study will be to define the optimal extend of lymphadenectomy to achieve the best oncological result. In addition, we will analyse the results dependent on the surgical access (open, laparoscopic or robotic). The assumed difference between the operative methods is small. Therefore, the study is designed and approved as a multicenter registration in order to achieve the necessary statistical power.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2021
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2021
CompletedFirst Submitted
Initial submission to the registry
March 18, 2024
CompletedFirst Posted
Study publicly available on registry
March 25, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2030
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 1, 2030
September 15, 2025
September 1, 2025
9.7 years
March 18, 2024
September 9, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Surgical complications defined by Calvien Dindo II to V
The primary aim of the project is to compare the impact of surgical radicality on clinical outcomes for right-sided colon cancer. The Clavien Dindo classification is a validated system ranging from I-V.
From the operation to discharge and readmission within 30 days
Secondary Outcomes (3)
Surgical quality described by the specimen quality and number of lymph nodes harvested
Postoperatively
Oncological quality will be measured by overall survival and recurrence
Postoperatively up to five years
Quality of life after surgery measured with the 15D instrument
2021 to 2024
Study Arms (3)
Access (Open, laparoscopic, robotic)
Outcomes will be analysed for the different groups
Extend of lymphadenectomy described by VAS score
The extend of lymphadenectomy achieved will be described by a visual analogue scale (VAS) after the operation
Quality of the specimen
The quality of the specimen will be documented postoperatively by a graded classification system
Interventions
Complications by Clavien Dindo Number of lymph nodes. Disease free and Overall survival
Eligibility Criteria
All patients with confirmed adenocarcinom of the right colon admitted to the hospital
You may qualify if:
- Patients with malignant tumor of the right colon at CT and/or colonoscopy.
- Confirmed adenocarcinoma
- Patients medically cleared by anesthesiologist for general anesthesia and oncological radical resection
- Informed consent
You may not qualify if:
- Patients under 18 years
- Patients with recurrent cancer after previous surgery
- Patients with ongoing treatment due to other cancer
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Haukeland University Hospitallead
- Intuitive Surgicalcollaborator
Study Sites (1)
Haukeland University Hospital
Bergen, 5009, Norway
Related Publications (5)
Lygre KB, Eide GE, Forsmo HM, Dicko A, Storli KE, Pfeffer F. Complications after open and laparoscopic right-sided colectomy with central lymphadenectomy for colon cancer: randomized controlled trial. BJS Open. 2023 Jul 10;7(4):zrad074. doi: 10.1093/bjsopen/zrad074.
PMID: 37643373BACKGROUNDLygre KB, Eide GE, Liedenbaum MH, Augland IMB, Haldorsen IS, Pfeffer F. Short and equal vascular stump length after standardized laparoscopic and open surgery with central lymphadenectomy for right-sided colon cancer. Br J Surg. 2024 Jan 3;111(1):znad410. doi: 10.1093/bjs/znad410. No abstract available.
PMID: 38064678BACKGROUNDSintonen H. The 15D instrument of health-related quality of life: properties and applications. Ann Med. 2001 Jul;33(5):328-36. doi: 10.3109/07853890109002086.
PMID: 11491191BACKGROUNDBenz S, Tannapfel A, Tam Y, Grunenwald A, Vollmer S, Stricker I. Proposal of a new classification system for complete mesocolic excison in right-sided colon cancer. Tech Coloproctol. 2019 Mar;23(3):251-257. doi: 10.1007/s10151-019-01949-4. Epub 2019 Mar 5.
PMID: 30838463BACKGROUNDPfeffer F, Kalgraff P, Lygre KB, Nedrebo BS, Forsmo HM. Proposal of a new visual analogue scale to describe the extent of lymphadenectomy in right-sided colectomy for cancer-a prospective observational study. Tech Coloproctol. 2025 Sep 2;29(1):166. doi: 10.1007/s10151-025-03182-8.
PMID: 40892141DERIVED
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Frank Pfeffer, Prof
Haukeland University Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 5 Years
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 18, 2024
First Posted
March 25, 2024
Study Start
January 1, 2021
Primary Completion (Estimated)
September 1, 2030
Study Completion (Estimated)
September 1, 2030
Last Updated
September 15, 2025
Record last verified: 2025-09
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR
- Time Frame
- 2024-2024
- Access Criteria
- signed cooperation agreement
All IPDs that underline results in a publication